 |
市場調查報告書
商品編碼
1137697
實驗室自動化軟件市場 - 增長、趨勢、COVID-19 影響和預測（2022-2027 年）Lab Automation Software Market - Growth, Trends, and Forecasts (2022 - 2027) |
||||||
價格
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
簡介目錄
在預測期間（2022-2027 年），實驗室自動化軟件市場預計將以 8.15% 的複合年增長率增長。
主要亮點
- 自動化用於從蛋白質組學到系統生物學的各種生命科學應用。通過使用軟件對專用工作站和儀器進行編程，自動化常規實驗室程序，助理科學家和工程師可以創造性地了解他們的實驗的含義，而不是把他們的時間花在乏味、重複的任務上。您將能夠思考和設計有用的後續行動項目或開發替代方法。
- 機器人技術與自動化的集成正在迅速增加，以提高生產力並降低實驗室運營成本。預計在預測期內將促進市場的增長。了解和發現生命本質的進展，例如聚合□鍊式反應 (PCR)、剪接基因和測序手段，正在興起，並可能推動市場增長。
- 此外，專家們認為自動化是臨床試驗數量呈指數增長的關鍵解決方案。數字化和自動化使科學家能夠自動化整個過程，從而減少污染、數字數據記錄和更快的數據處理。這大大減少了每次測試所需的時間。
- 自動化在幫助實驗室最大限度地提高效率、簡化操作、建立可擴展且可持續的方法以及最大限度地減少對服務和患者負責的服務的干擾方面發揮著關鍵作用然而，COVID-19 大流行的影響加劇了實驗室面臨的許多現有挑戰，包括人員短缺、TAT 改善和診斷測試錯誤減少。
- 設置實驗室自動化模塊（包括軟件）的成本偏高，令小型企業望而卻步。預計這一因素將阻礙預測期內的市場增長。
主要市場趨勢
實驗室信息管理系統有望佔據最大市場份額
- 實驗室信息管理系統行業在過去五年中經歷了強勁增長，因為實驗室對不斷增加的樣本量做出了反應，部分原因是人口老齡化導致對診斷測試的需求增加。
- 特別是，我們專注於開發軟件來解決業務問題，例如數據安全和合規性。該市場受到監管合規壓力增加、醫療保健系統集成需求增加、從遺留系統向商業 LIMS 解決方案遷移以及 LIMS 產品技術進步等因素的推動。
- 此外，對基因組和 DNA 等測試的資助增加了實驗室信息和數據。因此，基因組研究的興起對市場的增長產生了積極影響。高精度和消除手動數據轉錄錯誤等好處也有望推動市場發展。
- 根據美國國立衛生研究院 (NIH) 的數據，2021 年來自 NIH 的人類基因組資助預計約為 44.3 億美元，2022 年將達到 45.5 億美元。預計將推動市場增長。
- 北愛爾蘭衛生部長最近宣布推出耗資 4000 萬英鎊的新實驗室信息管理系統 (LIMS)，該系統將顯著改善醫療保健關鍵領域的臨床診斷服務交付。
預計亞太地區將成為增長最快的市場
- 由於製藥市場的快速增長，亞太地區是實驗室自動化軟件增長最快的地區。該地區的增長歸因於對藥物研發的投資增加。
- 例如，2022 年 5 月，美國製藥公司輝瑞 (Pfizer) 在印度的印度理工學院馬德拉斯研究園建立了亞洲首個全球藥物開發中心。該公司將在該中心投資 2000 萬美元，用於開發創新配方、小分子和活性藥物成分 (API)。
- 2022年2月，澳大利亞生物製藥公司維羅尼集團簽署合同，在中國珠海國家高新技術產業開發區建設新的研發中心。這些擴張舉措和投資預計將促進該地區的市場增長。
- 此外，與其他大陸不同，該地區擁有許多異質的人口群體，非常適合進行藥物研究。由於擁有熟練的勞動力和藥物開發的低成本，該地區被認為是外包藥物研究的首選目的地。
- 此外，其他地區的公司面臨嚴格的法規和漫長的工期，進一步增加了項目成本。因此，北美公司正在轉向與 CRO（合同研究組織）合作，該地區因贏得更多研究項目而受益最大。時間和預算是開發中最關鍵的因素，這就是製藥公司選擇自動化實驗室軟件的原因，這些軟件可以減少與藥物發現相關的錯誤、成本和時間。
- 例如，2021 年 10 月，韓國臨床診斷公司 GC Labs 推出了韓國首個微生物學全實驗室自動化系統 WASPLab。該解決方案可自動處理以前的樣本接收、接種、孵化和解釋等手動步驟。特別是，文化會自動確定為正面或負面。此外，檢查者可以查看監視器上的圖像並將最終結果報告給臨床專家。
競爭格局
實驗室自動化軟件市場的競爭不激烈，參與者數量也不多。更新的技術也正在出現，以自動化常規實驗室流程，例如測試和篩選。自動化工具可以實時處理並發請求，顯著提高生產力和吞吐量。
- 2022 年 3 月 - 由 Y Combinator 支持的生命科學實驗室信息化初創公司 Scispot 推出了 Labsheets，以幫助擺脫不科學的電子表格和過時的研究信息管理系統。已宣布。 Labsheets 是一種無代碼的關係數據庫產品，專門設計用於支持生命科學實驗室的數據管理、樣本跟蹤、審計跟蹤、自動報告和集成要求。 Scispot 的 Labsheets 目標是減少生命科學實驗室在電子表格中管理數據所花費的時間，讓實驗室專業人員能夠設計和自動化工作流程，從而更快地將科學突破推向市場。這樣做是為了加強生命科學實驗室。
- 2021 年 9 月 - Veeva Vault LIMS 是 Veeva Systems 的全新雲應用程序，旨在實現質量控制 (QC) 實驗室運營的現代化。通過將 Vault LIMS 整合到 Veeva Vault 質量套件中，製造商將能夠將其實驗室運營與更廣泛的質量生態系統無縫連接。這簡化了樣品管理、測試執行和實驗室研究流程，以加快批次發布並降低庫存成本。
- 2021 年 7 月 - LabVantage Solutions, Inc 推出了其旗艦產品 LabVantage LIMS 的 8.7 版，旨在為外部實驗室客戶提供安全的自助式門戶網站。升級後的 LabVantage LIMS 8.7 允許客戶保護有價值和敏感的數據，同時通過門戶在實驗室外擴展適當的訪問權限，無需手動請求測試和其他服務。
- 2021 年 7 月 - 分析實驗室 LIMS 軟件提供商 Promium, L.L.C. 宣布推出新版本的 Element LIMS 實驗軟件。 Element LIMS 是一個全面的實驗室信息管理系統，可管理整個實驗室的分析和運營活動。 Element LIMS 版本 7 包括增強功能、重新設計的用戶界面和新的開發框架，所有這些都旨在顯著提高實驗室性能和合規性。
其他好處
- Excel 格式的市場預測 (ME) 表
- 3 個月的分析師支持
內容
第1章介紹
- 研究假設和市場定義
- 調查範圍
第2章研究方法
第 3 章執行摘要
第 4 章市場洞察
- 市場概覽
- 工業吸引力 - 波特五力分析
- 供應商的議價能力
- 買家的議價能力
- 新進入者的威脅
- 替代品的威脅
- 競爭公司之間的敵對關係
- 工業價值鏈分析
- 評估 COVID-19 對市場的影響
第5章市場動態
- 市場驅動力
- 製藥和生物技術公司的研發活動增加
- 藥物發現和基因組學的需求增加
- 市場製約因素
- 初始設置成本很高，而且整個模塊可能很昂貴
第 6 章市場細分
- 通過軟件
- 實驗室信息管理系統 (LIMS)
- 實驗室信息系統 (LIS)
- 色譜數據系統 (CDS)
- 電子實驗室筆記本 (ELN)
- 科學數據管理系統 (SDMS)
- 按應用領域
- 藥物發現
- 基因組學
- 蛋白質組學
- 臨床診斷
- 其他應用領域
- 地區信息
- 北美
- 歐洲
- 亞太地區
- 世界其他地區
第 7 章競爭格局
- 公司簡介
- Thermo Fisher Scientific
- Danaher Corporation
- Hudson Robotics
- Becton, Dickinson & Company
- Synchron Lab Automation
- Agilent Technologies
- Siemens Healthineers AG
- Tecan Group Ltd
- Perkinelmer Inc.
- Bio-Rad Laboratories Inc.
- Roche Holding AG
- Eppendorf AG
- Shimadzu Corporation
第8章 投資分析
第9章 市場機會與將來動向
簡介目錄
Product Code: 54877
The Lab Automation Software Market is expected to grow at a CAGR of 8.15% during the forecast period (2022 to 2027).
Key Highlights
- Automation is used in various life science applications, from proteomics to systems biology. Automating routine laboratory procedures for using dedicated workstations and software to program instruments allows associate scientists and technicians to think creatively about the implications of their experimentation and to design useful follow-up projects or develop alternative approaches to their work instead of spending their days performing tasks with tedious repetition.
- The integration of robotics and automation is rapidly increasing, owing to enhanced productivity and mitigated laboratory operational costs. It is likely to boost market growth over the forecast period. The progress in understanding and the discovery of the nature of life, including the polymerase chain reaction (PCR), splice genes, and means of sequencing, are on the rise, which may propel the market growth.
- Additionally, the experts have credited automation as a crucial solution for the rapid increase in the number of clinical trials. With digitalization and automation, scientists were able to automate the whole process, which resulted in fewer contaminations, digital data recording, and faster processing of the data. This reduced the time taken by each trial significantly.
- Automation plays a key role in helping laboratories maximize efficiency, simplify operations and establish a scalable and sustainable approach to minimize disruption to the services they provide and the patients they serve. However, The impact of the COVID-19 pandemic worsened many of the existing challenges labs face with staffing shortages, improving TAT, and reducing diagnostic testing errors.
- The cost to set lab automation modules, including software, is on the higher side and discourages small enterprises. This factor is expected to hamper the market growth over the forecast period.
Key Market Trends
Laboratory Information Management System Expected to Have Largest Market Share
- The laboratory information management system industry exhibited robust growth over the past five years as laboratories grappled with an increase in sample volumes, partly due to the increased demand for diagnostic testing from the burgeoning elderly population.
- Industry operators have particularly focused on developing software that assists with operational issues, such as data security and regulatory compliance. This market is driven by certain factors, such as the rising pressure to comply with regulations, a growing need to integrate healthcare systems, a shift from legacy systems to commercial off-the-shelf LIMS solutions, and technological advancements in LIMS products.
- Moreover, the funding for tests, such as genome and DNA, has led to an increase in laboratory information and data. Therefore, the rising practice of genome study is favoring the market growth. Associated advantages, such as high precision and elimination of manual data transcription errors, are also anticipated to provide a boost to the market.
- According to NIH (National Institutes for Health), Human genome funding by the NIH was around 4.43 billion U.S. dollars in 2021, which is estimated at 4.55 billion U.S. dollars in 2022. such funding is also anticipated to boost the market.
- Northern Ireland's Minister of Health recently announced the launch of a new GBP 40 million Laboratory Information Management System (LIMS) that will significantly improve the delivery of clinical diagnostic services in key areas of healthcare.
Asia Pacific is Expected to be the Fastest Growing Market
- Asia-Pacific is the fastest-growing region for lab automation software, owing to the rapid growth in the pharmaceuticals market in this region. The growth can be attributed to the increased investment in pharmaceutical research and development in this region.
- For instance, in May 2022, US pharmaceutical company Pfizer set up its first global drug development center in Asia at the Indian Institute of Technology-Madras Research Park, India. The company has invested USD 20 million in the center to develop innovative formulations, small molecules, and active pharmaceutical ingredients (APIs).
- Also, in February 2022, Beroni Group, an Australia-based biopharmaceutical company, signed a contract to build a new R&D center in China's Zhuhai National High-Tech Industrial Development Zone. These expansion initiatives and investments are expected to boost the market growth in the region.
- Furthermore, this region is ideal for conducting pharmaceutical research due to the large pool of heterogeneous population groups, unlike other continents. This region is considered the most preferred to outsource pharmaceutical research, owing to the availability of skilled labor and lower cost required to develop drugs.
- Additionally, the companies in the other regions face stringent regulations and lengthy timelines, further escalating the project cost. Therefore, North American companies are shifting toward CRO (contract research organization) partnership, which has benefited this region the most to get more research projects. As time and the budget are the most crucial factors for the development, drug companies are opting for automated lab software that can reduce the errors, cost, and time-related to the discovery of the drug.
- For instance, in October 2021, GC Labs, a Korea-based clinical diagnostics company, introduced WASPLab, the first microbiology Total Laboratory Automation system in Korea. The solution automatically processes the steps from sample receipt to inoculation, culture, and interpretation, which had previously been conducted manually. In particular, it automatically interprets the culture as positive or negative. It allows test staff to double-check images on the monitor before reporting the final results to clinical professionals.
Competitive Landscape
The Lab Automation Software Market is neither highly competitive nor does it have a limited number of players. There are other newer technologies in the pipeline through which routine laboratory processes, such as testing and screening, are automated. Automation tools can process concurrent requests in real time, showing marked improvement in productivity and throughput.
- March 2022 - Scispot, a Y Combinator-backed life science lab informatics startup, introduces Labsheets to assist life science labs in moving beyond non-scientific spreadsheets and outdated lab information management systems. Labsheets is a no-code relational database product explicitly designed for life science labs to support their data management, sample tracking, audit trail, automated report creation, and integration requirements. Scispot's goal with Labsheets is to empower life science labs by reducing the time they spend managing data in spreadsheets, allowing lab professionals to design and automate workflows and bring scientific breakthroughs to market faster.
- September 2021 - Veeva Vault LIMS is a new cloud application from Veeva Systems designed to modernize quality control (QC) lab operations. By incorporating Vault LIMS into Veeva Vault Quality Suite, manufacturing organizations can seamlessly connect their lab operations with the broader quality ecosystem. This will speed up the batch release and lower inventory costs by streamlining sample management, test execution, and lab investigation processes.
- July 2021 - LabVantage Solutions, Inc has launched the 8.7 edition of its flagship LabVantage LIMS designed to provide a secure self-service web portal for the lab's external clients. With the upgraded LabVantage LIMS 8.7, customers can extend appropriate access rights outside the laboratory via the Portal while protecting their valuable and sensitive data, eschewing the need for manual requests for tests and other services.
- July 2021 - Promium, L.L.C., a provider of LIMS software for analytical testing laboratories, launched a new version of Element LIMS laboratory software. A comprehensive laboratory information management system, Element LIMS manages analytical and operational activities across the laboratory. Element LIMS version 7 includes feature enhancements, a redesigned user interface, and a new development framework, all targeted to increase laboratory performance and compliance significantly.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET INSIGHTS
- 4.1 Market Overview
- 4.2 Industry Attractiveness - Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Threat of Substitute Products
- 4.2.5 Intensity of Competitive Rivalry
- 4.3 Industry Value Chain Analysis
- 4.4 Assessment of the COVID-19 Impact on the Market
5 MARKET DYNAMICS
- 5.1 Market Drivers
- 5.1.1 Increasing Research and Development by Pharmaceutical and Biotech Companies
- 5.1.2 Growing Demand from Drug Discovery and Genomics
- 5.2 Market Restraints
- 5.2.1 Higher Initial Setup Costs Can be Expensive for Overall Module
6 MARKET SEGMENTATION
- 6.1 By Software
- 6.1.1 Laboratory Information Management System (LIMS)
- 6.1.2 Laboratory Information System (LIS)
- 6.1.3 Chromatography Data System (CDS)
- 6.1.4 Electronic Lab Notebook (ELN)
- 6.1.5 Scientific Data Management System (SDMS)
- 6.2 By Field of Application
- 6.2.1 Drug Discovery
- 6.2.2 Genomics
- 6.2.3 Proteomics
- 6.2.4 Clinical Diagnostics
- 6.2.5 Other Applications
- 6.3 By Geography
- 6.3.1 North America
- 6.3.2 Europe
- 6.3.3 Asia Pacific
- 6.3.4 Rest of the world
7 COMPETITIVE LANDSCAPE
- 7.1 Company Profiles
- 7.1.1 Thermo Fisher Scientific
- 7.1.2 Danaher Corporation
- 7.1.3 Hudson Robotics
- 7.1.4 Becton, Dickinson & Company
- 7.1.5 Synchron Lab Automation
- 7.1.6 Agilent Technologies
- 7.1.7 Siemens Healthineers AG
- 7.1.8 Tecan Group Ltd
- 7.1.9 Perkinelmer Inc.
- 7.1.10 Bio-Rad Laboratories Inc.
- 7.1.11 Roche Holding AG
- 7.1.12 Eppendorf AG
- 7.1.13 Shimadzu Corporation
